Advertisement

Topics

H3 Biomedicine to Present New Data from Recent Research Advancements at 2017 American Association of Cancer Research Annual Meeting

08:00 EST 9 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
H3 Biomedicine Inc., a clinical stage biopharmaceutical company specializing in the discovery and development of precision medicines for oncology and a member of Eisai’s global Oncology Business Group, announced today that com...

Other Sources for this Article

Media Inquiries:
H3 Biomedicine
Paul Kidwell, 617-680-1088

NEXT ARTICLE

More From BioPortfolio on "H3 Biomedicine to Present New Data from Recent Research Advancements at 2017 American Association of Cancer Research Annual Meeting"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...